Posts by tag
Rare cancers
Drug repurposing: EU legislative changes could speed up new treatment options
The length of time it takes for each new cancer drug to reach the market – and more importantly, the patient – remains a cause of deep frustration particularly among those whose lives depend on accessing new options. Concrete data…
Europe’s patient advocates skill up to better influence cancer care and research agendas
Patient advocates for a wide range of cancer communities across Europe spent four days at the start of July honing the skills they need to influence the policy, research and healthcare decisions that matter to them. This was the second…
How organoids could help match treatments to tumours
When diagnosed with cancer, few things are more important than having confidence that the treatment you are prescribed is the best possible option for you. For many cancers, particularly the more common ones, the evidence for choosing one option over…
Rare cancer care: Are European Reference Networks delivering on the promise?
What value can collaboration between EU member states add to the quality of care accessible to all EU citizens? It’s a question that has become urgent and topical with the coronavirus pandemic, and one that EU4Health, the EU’s new funding…